A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?
Curr Opin Lipidol. 2026 Apr 7. doi: 10.1097/MOL.0000000000001040. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Janus kinase (JAK) inhibitors have emerged as potent anti-inflammatory drugs and are prescribed in rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). However, cardiovascula

